Latest News

Frost Sullivan

PQ Bypass Wins 2017 Innovation Award

31st August 2017

LONDON, U.K. August 31, 2017. Frost & Sullivan has announced PQ Bypass as winner of the 2017 European PAD Interventions Technology Innovation Award. Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that […]

Read More
Gordie Nye News

Atlantic Therapeutics appoints Gordie Nye as Chairman

26th July 2017

Seroba’s investee company, Atlantic Therapeutics, which is focused on treating conditions of the pelvic floor and surrounding tissues, has appointed Gordie Nye as its Chairman. After working with Gillette and Reebok, Gordie Nye forged his career as a CEO and […]

Read More
Prexton News

Prexton announces clinical testing in Parkinson’s disease

10th July 2017

Seroba’s investee company, Prexton Therapeutics (Prexton), a biopharma company developing novel therapeutic compounds for the treatment of Central Nervous System (CNS) conditions, today announces the launch of phase II clinical testing of its investigational drug candidate, Foliglurax, in Parkinson’s disease […]

Read More
Alforex News

Alflorex® Wins Best Gastrointestinal Product Award

29th April 2017

Alflorex® has won the best Gastrointestinal product for the second year running in the highly regarded Irish Pharmacy News (IPN) Awards 2017.  These awards acknowledge the innovation, dedication, and achievements from some of the leading companies in the pharmacy sector. Alflorex® has […]

Read More
Atlantic News

Atlantic Therapeutics receives €15 million in funding round

29th March 2017

Atlantic Therapeutics Group Ltd, the Galway-headquartered medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products, has successfully completed a €15 million growth capital financing, enabling it to move forward with its next phase of growth and treat […]

Read More
Medlumics News

MedLumics Secures €34m in Series B Funding

20th March 2017

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised 34.4 million Euros in financing that will be used to help advance the product and clinical development of the company’s AblaView catheter, […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top